As sleep health gains prominence in preventative and personalised medicine, a new generation of startups is driving innovation in insomnia treatment and sleep optimisation. MedicalStartups.org has released its 2025 ranking of the top 19 companies leading the way in this space—ranging from advanced wearables and AI-driven diagnostics to novel therapeutics and remote monitoring solutions.
These organisations are not only improving clinical outcomes for individuals affected by sleep disorders, but also attracting significant investor interest across Europe, North America, and Asia-Pacific.
Companies of Note
Oura Health (Finland, $223.3M raised)
Oura's data-driven wearable ring enables users to monitor key biometric signals including sleep cycles, heart rate variability, and recovery trends—empowering both consumers and clinicians with actionable insights into sleep quality.
Apnimed (USA, $207.8M)
Focused on pharmacological solutions, Apnimed is developing novel oral therapies for obstructive sleep apnea and related conditions, offering an alternative to device-based interventions.
Eight Sleep (USA, $162.1M)
Eight Sleep integrates biometric tracking and thermal regulation into its smart mattress technology, positioning itself at the intersection of sleep science and performance optimisation.
Dreem (France, $57M)
Dreem's EEG-enabled headband uses real-time brainwave analysis and auditory stimulation to enhance sleep quality—applying clinical neuroscience in a consumer-ready format.
Onera (Netherlands, $54.4M)
Onera has developed wireless medical-grade sleep diagnostics for at-home use, reducing the need for in-lab sleep studies and increasing accessibility for early detection of sleep disorders.
Other innovators in the 2025 ranking include:
-
BetterNight (USA) – telehealth for sleep disorder treatment
-
ChiliSleep (USA) – temperature-regulating sleep systems
-
Sunrise (Belgium) – AI-powered, single-sensor sleep diagnostics
-
Meditopia (Germany) – digital mental wellness and mindfulness
-
HoneyNaps (South Korea) – biosignal monitoring to support clinical decisions
-
Huckleberry (USA) – AI sleep plans for children
-
Acurable (UK) – at-home respiratory health monitoring
-
Sleep Data (USA) – virtual care for sleep and fatigue
-
Arcascope (USA) – circadian rhythm optimisation
-
Pulsetto (Lithuania) – vagus nerve stimulation for stress and sleep
-
Neurobit Technologies (Singapore) – AI infrastructure for sleep-focused devices
-
NightWare (USA) – FDA-cleared therapy for PTSD-related nightmares
Strategic Implications
From digital therapeutics to neurotechnology and remote diagnostics, the sleep-health sector is attracting strong cross-border investment and healthcare interest. These 19 companies exemplify how sleep science is converging with innovation, reshaping both consumer wellness and clinical care.